SCHEMBL681327

SCHEMBL681327

CC(C)C(=O)[C@@H](Cc1ccc(Cl)cc1)NCCN1CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALDH1A1 P00352 2/20 0.47
CNR1 P21554 1/20 0.46
TSHR P16473 1/20 0.46
KDM4E B2RXH2 1/20 0.46
HRH3 Q9Y5N1 2/20 0.45
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TACR2 P21452 1/20 0.43
TACR1 P25103 1/20 0.43
CACNA1G O43497 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL681503 0.88 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1CNR1NPSR1TACR2
SCHEMBL681837 0.79 ACACB (0.42) GAAALDH1A1TSHRKDM4E
SCHEMBL681663 0.79 BCHE (0.50) SMN1; SMN2ALDH1A1
SCHEMBL14295176 0.76 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1CNR1NPSR1TACR2
SCHEMBL681060 0.75 HTRA1 (0.46) GAASMN1; SMN2CYP3A4CYP2D6CYP2C19
SCHEMBL20892764 0.75 ACACB (0.44) GAASMN1; SMN2ALDH1A1TSHR
SCHEMBL680890 0.75 ACACB (0.44) GAASMN1; SMN2ALDH1A1TSHR
SCHEMBL10266645 0.74 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1CNR1TACR2
SCHEMBL680880 0.74 GAA (0.44) GAASMN1; SMN2ALDH1A1TSHR
SCHEMBL681500 0.73 SLC6A2 (0.46) GAASMN1; SMN2ALDH1A1TSHRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359340-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2016-06-07 US disclosed
US-8063050-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2011-11-22 US disclosed